• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商业凝血酶生成测定中分析前变量的评估

Evaluation of pre-analytical variables in a commercial thrombin generation assay.

作者信息

Rodgers Susan E, Wong Amanda, Gopal Reanuga D, Dale Brian J, Duncan Elizabeth M, McRae Simon J

机构信息

Haematology Division, IMVS, SA Pathology, Adelaide, SA, Australia; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.

School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.

出版信息

Thromb Res. 2014 Jul;134(1):160-4. doi: 10.1016/j.thromres.2014.04.010. Epub 2014 Apr 22.

DOI:10.1016/j.thromres.2014.04.010
PMID:24792772
Abstract

BACKGROUND

There is minimal data on the influence of pre-analytical variables on the use of calibrated automated thrombography (CAT), to measure thrombin generation.

OBJECTIVES

To evaluate the impact of centrifugation methods, time after collection, and contact activation inhibition on the CAT assay performed using two commercial reagents.

METHODS AND RESULTS

Six different methods of plasma separation were examined. Thrombin generation triggered by a 5 pM tissue factor reagent was not greatly affected by plasma separation method, with similar results obtained with all methods apart from single centrifugation and membrane filtration. Membrane filtration increased APTT and is not recommended. Extended double centrifugation at higher speed was required to minimise the impact of residual phospholipid with 1 pM tissue factor trigger, particularly with inhibition of contact activation. The effect of a delay of up to 24 hours in preparing plasma was assessed. No significant difference in results was observed among samples processed between 0.5 and 6 hours after blood collection into plastic Vacuette® tubes. The presence or absence of corn trypsin inhibitor had a significant impact on all parameters with 1 pM tissue factor trigger, with minor differences seen on Peak and ttPeak results using 5 pM tissue factor.

CONCLUSIONS

The impact of pre-analytical variables on thrombin generation results is dependent on the concentration of tissue factor in the trigger reagent used. Results with 1 pM tissue factor are particularly sensitive to centrifugation method and contact activation, and standardisation is required to allow large collaborative studies to be performed.

摘要

背景

关于分析前变量对校准自动血栓形成测定法(CAT)用于测量凝血酶生成的影响的数据极少。

目的

评估离心方法、采血后时间以及接触激活抑制对使用两种商业试剂进行的CAT测定的影响。

方法与结果

检查了六种不同的血浆分离方法。由5 pM组织因子试剂触发的凝血酶生成受血浆分离方法的影响不大,除了单次离心和膜过滤外,所有方法得到的结果相似。膜过滤会增加活化部分凝血活酶时间(APTT),不建议使用。对于1 pM组织因子触发物,需要更高速度的延长双离心以最小化残留磷脂的影响,特别是在接触激活受到抑制时。评估了血浆制备延迟长达24小时的影响。在血液采集到塑料Vacuette®管后0.5至6小时内处理的样本之间,未观察到结果有显著差异。玉米胰蛋白酶抑制剂的存在与否对1 pM组织因子触发物的所有参数有显著影响,使用5 pM组织因子时,在峰值和ttPeak结果上有微小差异。

结论

分析前变量对凝血酶生成结果 的影响取决于所用触发试剂中组织因子的浓度。1 pM组织因子的结果对离心方法和接触激活特别敏感,需要标准化以进行大型协作研究。

相似文献

1
Evaluation of pre-analytical variables in a commercial thrombin generation assay.商业凝血酶生成测定中分析前变量的评估
Thromb Res. 2014 Jul;134(1):160-4. doi: 10.1016/j.thromres.2014.04.010. Epub 2014 Apr 22.
2
Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?监测凝血酶生成:是否需要添加玉米胰蛋白酶抑制剂?
Thromb Haemost. 2009 Jun;101(6):1156-62.
3
Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.健康成人和儿童血浆中的凝血酶生成:发色底物法与荧光底物法血栓图分析
Thromb Haemost. 2007 Sep;98(3):600-13.
4
Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition.通过校准自动血栓形成描记法进行凝血酶生成的临床测量需要接触因子抑制。
J Thromb Haemost. 2004 Nov;2(11):1954-9. doi: 10.1111/j.1538-7836.2004.00964.x.
5
Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.(分析前)变量对通过基于凝血酶生成的检测方法测定的活化蛋白C抵抗的影响。
Thromb Haemost. 2002 Mar;87(3):483-92.
6
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.在荧光凝血酶生成检测中,玉米胰蛋白酶抑制剂仅在低组织因子浓度时是必需的,并且会影响凝血因子 VIII 促凝活性与血栓图参数之间的关系。
Blood Coagul Fibrinolysis. 2008 Apr;19(3):183-9. doi: 10.1097/MBC.0b013e3282f4bb47.
7
Analytical and between-subject variation of thrombin generation measured by calibrated automated thrombography on plasma samples.通过校准自动血栓形成分析仪对血浆样本进行凝血酶生成检测的分析性变异和个体间变异。
Scand J Clin Lab Invest. 2018 May;78(3):175-179. doi: 10.1080/00365513.2018.1427280. Epub 2018 Jan 16.
8
Measurements of endogenous thrombin potential using the CAT method in cats: Reference values and influence of the direct factor Xa inhibitor apixaban.采用 CAT 法测定猫体内源性凝血酶潜能:参考值及直接因子 Xa 抑制剂阿哌沙班的影响。
Res Vet Sci. 2019 Dec;127:113-121. doi: 10.1016/j.rvsc.2019.08.030. Epub 2019 Aug 28.
9
Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.血友病A中校准的自动凝血酶生成和改良血栓弹力图检测
Thromb Res. 2009 Apr;123(6):895-901. doi: 10.1016/j.thromres.2008.09.011. Epub 2008 Nov 13.
10
Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.接触激活:在使用含磷脂试剂测量组织因子载小微粒对凝血酶生成的贡献时,需要考虑的重要因素。
J Thromb Haemost. 2014 Apr;12(4):515-8. doi: 10.1111/jth.12503.

引用本文的文献

1
Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance.重新审视血液离心对凝血酶生成测定参数的影响,以寻求对当前指南进行可能的修订。
Pract Lab Med. 2025 May 31;45:e00478. doi: 10.1016/j.plabm.2025.e00478. eCollection 2025 Jul.
2
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy.诱导治疗后新诊断的多发性骨髓瘤患者全自动凝血酶生成显著减弱。
J Thromb Thrombolysis. 2025 Mar;58(3):467-480. doi: 10.1007/s11239-025-03079-1. Epub 2025 Mar 10.
3
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
抗磷脂抗体阳性患者的凝血酶生成试验作为一种个体化血栓风险评估:现状与展望。
Curr Rheumatol Rep. 2024 May;26(5):178-187. doi: 10.1007/s11926-024-01140-1. Epub 2024 Feb 19.
4
External validation of the MidiCAT variant of thrombography: Comparison with calibrated automated thrombography and study of the centrifugation scheme.血栓形成检测法MidiCAT变体的外部验证:与校准自动血栓形成检测法的比较及离心方案研究
Front Cardiovasc Med. 2022 Oct 21;9:998687. doi: 10.3389/fcvm.2022.998687. eCollection 2022.
5
Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease.凝血酶生成试验用于预测成年镰状细胞病血管闭塞性危象的研究。
Front Cardiovasc Med. 2022 Oct 5;9:883812. doi: 10.3389/fcvm.2022.883812. eCollection 2022.
6
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system.基于内源性凝血酶原时间的活化蛋白 C 抵抗检测在自动化 ST Genesia 系统上的分析性能。
Res Pract Thromb Haemost. 2022 Apr 7;6(3):e12684. doi: 10.1002/rth2.12684. eCollection 2022 Mar.
7
Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia Analysers and Three Thrombin Generation Methods, in APS and SLE Patients.在抗磷脂综合征(APS)和系统性红斑狼疮(SLE)患者中,使用CAT分析仪和ST-Genesia分析仪以及三种凝血酶生成方法对获得性活化蛋白C抵抗进行比较。
J Clin Med. 2021 Dec 23;11(1):69. doi: 10.3390/jcm11010069.
8
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations.关于新冠病毒病止血方面的研究,需要对实验室方法、其意义及局限性进行详尽报道。
J Thromb Haemost. 2020 Nov;18(11):3121-3124. doi: 10.1111/jth.15061.
9
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.在一组健康成年人中使用ST Genesia凝血酶生成系统进行凝血酶生成测量:正常值和变异性。
Res Pract Thromb Haemost. 2019 Jul 18;3(4):758-768. doi: 10.1002/rth2.12238. eCollection 2019 Oct.
10
Risk of Thrombosis in Patients Presenting with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA).非阻塞性冠状动脉心肌梗死(MINOCA)患者的血栓形成风险
TH Open. 2018 May 3;2(2):e167-e172. doi: 10.1055/s-0038-1645875. eCollection 2018 Apr.